The United States Food & Drug Administration (US FDA) approval extends the breadth of the Montelukast offerings from Ajanta Pharma into three dosage forms (Immediate-Release Tablets, Chewable Tablets, and Oral Granules).
Montelukast IR Tablets and Chewable Tablets are part of an ever-growing portfolio that Ajanta Pharma has developed for the US market.